Norgestrel and ethinyl estradiol and Kanamycin - serum - a phase IV clinical study of FDA data


We study 604 people who take Norgestrel and ethinyl estradiol or have Kanamycin - serum. No report of Kanamycin - serum is found in people who take Norgestrel and ethinyl estradiol.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2022

No report is found.

What is Norgestrel And Ethinyl Estradiol?

Norgestrel and ethinyl estradiol has active ingredients of ethinyl estradiol; norgestrel. eHealthMe is studying from 302 Norgestrel and ethinyl estradiol users for its effectiveness, alternative drugs and more.

What is Kanamycin - Serum?

Kanamycin - serum is found to be associated with 1 drug and 2 conditions by eHealthMe.

Do you take Norgestrel and ethinyl estradiol and have Kanamycin - serum?

Check whether Kanamycin - serum is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Kanamycin - serum and when was it recovered:

Expand to all the drugs that have ingredients of ethinyl estradiol; norgestrel:

Alternative drugs to, pros and cons of Norgestrel and ethinyl estradiol:

Kanamycin - serum treatments and more:

COVID vaccines that are related to Kanamycin - serum:

All the drugs that are associated with Kanamycin - serum:

All the conditions that are associated with Kanamycin - serum:

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestrel (the active ingredients of Norgestrel and ethinyl estradiol) and Norgestrel and ethinyl estradiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: